gaia-group
The company GAIA AG is a global leader in digital health, collaborating with major industry players, health insurance companies, medical organizations, and universities worldwide. They develop innovative therapeutic software and emphasize scientific, technological, and therapeutic expertise in their operations.
GAIA is a research‑based public health company (active since 1997) that develops evidence‑based, safe and accessible digital therapeutics to support mental and physical health. With over 20 years of experience and more than 70 products, a multidisciplinary team of physicians, psychotherapists, clinical scientists, engineers and regulatory/market‑access specialists builds, launches and maintains DTx for major markets. Their programs are clinically validated in numerous randomized controlled trials (GAIA cites >19 RCTs and 2 meta‑analyses), notably deprexis®, an online treatment for depression evaluated in multiple RCTs. GAIA emphasizes data security and regulatory compliance (ISO 27001, HIPAA, TÜV) and partners with healthcare providers, payers and industry stakeholders.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for gaia-group.
gaia-group didn’t post a salary, so this is our estimate from similar listings.